![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Correction to: Deciphering the focal role of endostatin in Alzheimer’s disease
-
Article
Correction to: Targeting cellular batteries for the therapy of neurological diseases
-
Article
Correction to: Connecting the dots between mitochondrial dysfunction and Parkinson’s disorder: focus mitochondria-targeting therapeutic paradigm in mitigating the disease severity
-
Article
Open AccessAdvancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Breast cancer is the second leading cause of death for women worldwide. The heterogeneity of this disease presents a big challenge in its therapeutic management. However, recent advances in molecular biology a...
-
Article
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
COVID-19 disease has been identified to cause remarkable increase of mucormycosis infection cases in India, with the majority of cases being observed in individuals recovering from COVID-19. Mucormycosis has e...
-
Article
A motley of possible therapies of the COVID-19: reminiscing the origin of the pandemic
The 2019 outbreak of corona virus disease began from Wuhan (China), transforming into a leading pandemic, posing an immense threat to the global population. The WHO coined the term nCOVID-19 for the disease on...
-
Article
Retraction Note to: Exploring the Role of CLU in the Pathogenesis of Alzheimer’s Disease
-
Article
Targeting natural products against SARS-CoV-2
The human coronavirus disease (COVID-19) pandemic is caused by a novel coronavirus; the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2). Natural products, secondary metabolites show positive leads w...
-
Article
Anticipated pharmacological role of Aviptadil on COVID-19
Vasoactive intestinal peptide (VIP) is a neuropeptide that is produced by the lymphoid cells and plays a major role in immunological functions for controlling the homeostasis of the immune system. VIP has been...
-
Article
RETRACTED ARTICLE: Role of TLR2 and TLR4 Signaling in Parkinson’s Disease: An Insight into Associated Therapeutic Potential
-
Article
Deciphering the role of nanoparticles for management of bacterial meningitis: an update on recent studies
Meningitis is an inflammation of the protective membranes called meninges and fluid adjacent the brain and spinal cord. The inflammatory progression expands all through subarachnoid space of the brain and spin...
-
Article
Pertinence of nutriments for a stalwart body
Nutrition plays a significant role in the prevention and treatment of common diseases. Some superb dietary choices such as functional foods and nutriments can surely help fight against certain diseases and pro...
-
Article
Artificial intelligence as a fundamental tool in management of infectious diseases and its current implementation in COVID-19 pandemic
The world has never been prepared for global pandemics like the COVID-19, currently posing an immense threat to the public and consistent pressure on the global healthcare systems to navigate optimized tools, ...
-
Article
Uncurtaining the effect of COVID-19 in diabetes mellitus: a complex clinical management approach
The aim of the present review is to overview the common properties of corona virus and hence proofs well beginning of corona virus in persons with diabetes, and its treatment. Globally, it has been observed th...
-
Article
Genetic Diversity of SARS-CoV2 and Environmental Settings: Possible Association with Neurological Disorders
The new coronavirus (CoV), called novel coronavirus disease 2019 (COVID-19), belongs to the Coronaviridae family which was originated from the sea market in Wuhan city in China, at the end of the year 2019. CO...
-
Article
Open AccessCross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
Current therapies for Parkinson’s disease (PD) are palliative, of which the levodopa/carbidopa therapy remains the primary choice but is unable to modulate the progression of neurodegeneration. Due to the comp...
-
Article
Correction to: Exploring the Role of CLU in the Pathogenesis of Alzheimer’s Disease
The original article has been corrected. Author Md. Ghulam Md Ashraf“ should be “Ghulam Md Ashraf”.